PEDIATRICS Vol. 63 No. 2 February 1979, pp. 175-179
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, H.
Right arrow Articles by Yokoyama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, H.
Right arrow Articles by Yokoyama, T.

Kawasaki Disease: Effect of Treatment on Coronary Artery Involvement

Hirohisa Kato M.D.1, Sigeyuki Koike M.D.1, and Takashi Yokoyama M.D.1

1 Department of Pediatrics and Child Health, Kurume (Japan) University Hospital

Ninety-two patients with Kawasaki disease were treated with five different types of drug therapy: a steroid preparation (prednisolone), aspirin, an antibiotic, a combination of steroid plus aspirin, and a combination of steroid plus warfarin. One to two months after the onset of the disease, coronary angiography demonstrated coronary aneurysms in 20% of cases treated with an antibiotic alone, 64.7% of cases in the steroid-treated group, and 11% of those in the aspirin-treated group.

These findings suggest that the steroid might act adversely to cause a progression of coronary lesions of the disease. The aspirin-treated group did not have a significantly lower incidence of coronary lesions compared with the group treated with an antibiotic alone. But in view of the fact that the direct cause of sudden death of the disease is thrombotic occlusion of a coronary artery, aspirin might act as the effective means for prevention of sudden death due to Kawasaki disease.

Submitted on November 4, 1977
Accepted on June 20, 1978




This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
T Furukawa, M Kishiro, K Akimoto, S Nagata, T Shimizu, and Y Yamashiro
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease
Arch. Dis. Child., February 1, 2008; 93(2): 142 - 146.
[Abstract] [Full Text] [PDF]

Home page
 AAP Grand RoundsHome page
D. Danford and S. C. Li
Is There a Role for Corticosteroids in Treatment of Kawasaki Disease?
AAP Grand Rounds, May 1, 2007; 17(5): 49 - 50.
[Full Text] [PDF]

Home page
 NEJMHome page
J. W. Newburger, L. A. Sleeper, B. W. McCrindle, L. L. Minich, W. Gersony, V. L. Vetter, A. M. Atz, J. S. Li, M. Takahashi, A. L. Baker, et al.
Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease
N. Engl. J. Med., February 15, 2007; 356(7): 663 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
H Senzaki
The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases
Arch. Dis. Child., October 1, 2006; 91(10): 847 - 851.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. C. Wooditch and S. C. Aronoff
Effect of Initial Corticosteroid Therapy on Coronary Artery Aneurysm Formation in Kawasaki Disease: A Meta-analysis of 862 Children
Pediatrics, October 1, 2005; 116(4): 989 - 995.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
S. Takeshita, Y. Kawamura, K. Nakatani, H. Tsujimoto, and T. Tokutomi
Standard-dose and Short-term Corticosteroid Therapy in Immunoglobulin-resistant Kawasaki Disease
Clinical Pediatrics, June 1, 2005; 44(5): 423 - 426.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al.
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
Pediatrics, December 1, 2004; 114(6): 1708 - 1733.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al.
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
Circulation, October 26, 2004; 110(17): 2747 - 2771.
[Abstract] [Full Text] [PDF]

Home page
 AAP Grand RoundsHome page
M. H. Rathore
When Should Corticosteroids Be Used for the Management of Kawasaki Disease?
AAP Grand Rounds, October 1, 2003; 10(4): 43 - 44.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
Y Uziel, P J Hashkes, E Kassem, G Gottesman, and B Wolach
"Unresolving pneumonia" as the main manifestation of atypical Kawasaki disease
Arch. Dis. Child., October 1, 2003; 88(10): 940 - 942.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
H. C. Meissner and D. Y. M. Leung
Kawasaki Syndrome: Where Are the Answers?
Pediatrics, September 1, 2003; 112(3): 672 - 676.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
F. T. Saulsbury
Comparison of High-Dose and Low-Dose Aspirin Plus Intravenous Immunoglobulin in the Treatment of Kawasaki Syndrome
Clinical Pediatrics, October 1, 2002; 41(8): 597 - 601.
[Abstract] [PDF]

Home page
 Arch. Dis. Child.Home page
P A Brogan, A Bose, D Burgner, D Shingadia, R Tulloh, C Michie, N Klein, R Booy, M Levin, and M J Dillon
Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research
Arch. Dis. Child., April 1, 2002; 86(4): 286 - 290.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
I Vlahos and K McHugh
A nipper from Nippon?
Br. J. Radiol., March 1, 2002; 75(891): 289 - 290.
[Full Text] [PDF]

Home page
 AAP Grand RoundsHome page
S. T. Shulman
Severe, Complicated Kawasaki Disease Treated With Corticosteroids
AAP Grand Rounds, February 1, 2001; 5(2): 11 - 11.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
R. K. Han, E. D. Silverman, A. Newman, and B. W. McCrindle
Management and Outcome of Persistent or Recurrent Fever After Initial Intravenous Gamma Globulin Therapy in Acute Kawasaki Disease
Arch Pediatr Adolesc Med, July 1, 2000; 154(7): 694 - 699.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. A. Wallace, J. W. French, S. J. Kahn, and D. D. Sherry
Initial Intravenous Gammaglobulin Treatment Failure in Kawasaki Disease
Pediatrics, June 1, 2000; 105(6): 78e - 78.
[Abstract] [Full Text]

Home page
 HeartHome page
M Iemura, M Ishii, T Sugimura, T Akagi, and H Kato
Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function
Heart, March 1, 2000; 83(3): 307 - 311.
[Abstract] [Full Text]

Home page
 Vasc MedHome page
J. W Newburger and J. C Burns
Kawasaki disease
Vascular Medicine, August 1, 1999; 4(3): 187 - 202.
[Abstract] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. H. Rowley and S. T. Shulman
Kawasaki Syndrome
Clin. Microbiol. Rev., July 1, 1998; 11(3): 405 - 414.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Kato, T. Sugimura, T. Akagi, N. Sato, K. Hashino, Y. Maeno, T. Kazue, G. Eto, and R. Yamakawa
Long-term Consequences of Kawasaki Disease: A 10- to 21-Year Follow-up Study of 594 Patients
Circulation, September 15, 1996; 94(6): 1379 - 1385.
[Abstract] [Full Text]

Home page
 Arch SurgHome page
J. M. Reilly, E. B. Savage, C. M. Brophy, and M. D. Tilson
Hydrocortisone Rapidly Induces Aortic Rupture in a Genetically Susceptible Mouse
Arch Surg, June 1, 1990; 125(6): 707 - 709.
[Abstract] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
M. M. April, J. C. Burns, J. W. Newburger, and G. B. Healy
Kawasaki Disease and Cervical Adenopathy
Arch Otolaryngol Head Neck Surg, April 1, 1989; 115(4): 512 - 514.
[Abstract] [PDF]